Aardvark Therapeutics Inc... (AARD)
NASDAQ: AARD
· Real-Time Price · USD
12.67
0.50 (4.11%)
At close: Sep 25, 2025, 3:59 PM
12.67
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT
4.11% (1D)
| Bid | 11.44 |
| Market Cap | 274.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -36.64M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -7.5 |
| Forward PE | -3.79 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 13 |
| Volume | 124,816 |
| Avg. Volume (20D) | 120,550 |
| Open | 11.97 |
| Previous Close | 12.17 |
| Day's Range | 11.68 - 12.98 |
| 52-Week Range | 4.88 - 19.58 |
| Beta | 2.64 |
| Ex-Dividend Date | n/a |
About AARD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AARD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AARD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+11.55%
Aardvark Therapeutics shares are trading lower aft...
Unlock content with
Pro Subscription
5 months ago
+10.39%
Aardvark Therapeutics shares are trading higher after RBC Capital and Cantor Fitzgerald reiterated their respective ratings on the stock and maintained their price targets.
